BioWorld MedTech

July 23, 2014

View Archived Issues

Boston Scientific receives PMA for its Rebel Platinum Chromium BMS

Despite the adoption rates of drug-eluting stents (DES), device makers haven't totally abandoned bare metal stents (BMS). One only has to look at Boston Scientific's (Natick, Massachusetts) most recent product approval as evidence. Read More

World in Review: Oraya Therapeutics expanding AMD wet therapy into Europe

Read More

FDA releases documents under IMDRF's single audit program

Read More

EPs in Europe gain access to new FlexAbility catheter from St. Jude

Read More

Daily M&A: Kindred ups its offer for Gentiva to $17.25 a share, subject to 'diligence'

Read More

Agreements/Contracts: Christie NHS to join consortium to develop radiotherapy system

Read More

Patent Watch: Neodyne Biosciences receives Korean patent for treatment of Keloids

Read More

Hit Bits: New security consulting services aim to protect medical device cybersecurity

Read More

Briefly noted

Read More

Products

Read More

People in Places

Read More

MDD's Cardiology Extra

Read More